Literature DB >> 27283172

Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.

Filipa Lynce, Claudine Isaacs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27283172      PMCID： PMC5987769          DOI： 10.6004/jnccn.2016.0081

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  27 in total

1.  Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.

Authors:  Elisa F Long; Patricia A Ganz
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

2.  A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.

Authors:  Catherine M Phelan; Elaine Kwan; Elaine Jack; Song Li; Cindy Morgan; Jennifer Aubé; Danielle Hanna; Steven A Narod
Journal:  Hum Mutat       Date:  2002-11       Impact factor: 4.878

3.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

4.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Authors:  Nasim Mavaddat; Susan Peock; Debra Frost; Steve Ellis; Radka Platte; Elena Fineberg; D Gareth Evans; Louise Izatt; Rosalind A Eeles; Julian Adlard; Rosemarie Davidson; Diana Eccles; Trevor Cole; Jackie Cook; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Shirley Hodgson; Lisa Walker; Mary E Porteous; Patrick J Morrison; Lucy E Side; M John Kennedy; Catherine Houghton; Alan Donaldson; Mark T Rogers; Huw Dorkins; Zosia Miedzybrodzka; Helen Gregory; Jacqueline Eason; Julian Barwell; Emma McCann; Alex Murray; Antonis C Antoniou; Douglas F Easton
Journal:  J Natl Cancer Inst       Date:  2013-04-29       Impact factor: 13.506

5.  Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.

Authors:  Marc D Schwartz; Beth N Peshkin; Chanita Hughes; David Main; Claudine Isaacs; Caryn Lerman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

Review 6.  A literature review of the psychological impact of genetic testing on breast cancer patients.

Authors:  Kathryn J Schlich-Bakker; Herman F J ten Kroode; Margreet G E M Ausems
Journal:  Patient Educ Couns       Date:  2005-10-19

7.  Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.

Authors:  K A Metcalfe; A Poll; M Llacuachaqui; S Nanda; A Tulman; N Mian; P Sun; S A Narod
Journal:  Clin Genet       Date:  2010-07-28       Impact factor: 4.438

8.  Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations.

Authors:  D Schrag; K M Kuntz; J E Garber; J C Weeks
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

9.  Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients.

Authors:  Juliette Christie; Gwendolyn P Quinn; Teri Malo; Ji-Hyun Lee; Xiuhua Zhao; Jessica McIntyre; Jennifer Brzosowicz; Paul B Jacobsen; Susan T Vadaparampil
Journal:  Ann Surg Oncol       Date:  2012-07-06       Impact factor: 5.344

10.  Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.

Authors:  Kelly A Metcalfe; Aletta Poll; Robert Royer; Marcia Llacuachaqui; Anna Tulman; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544
View more
  2 in total

1.  Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study.

Authors:  Kelly M Morgan; Jada G Hamilton; Heather Symecko; Daniella Kamara; Colby Jenkins; Jenny Lester; Kelsey Spielman; Lydia E Pace; Camila Gabriel; Jeffrey D Levin; Prince Rainier Tejada; Anthony Braswell; Vanessa Marcell; Temima Wildman; Bryan Devolder; Robin Camhi Baum; Jeremy N Block; Yuri Fesko; Kylin Boehler; Victoria Howell; Jacob Heitler; Mark E Robson; Katherine L Nathanson; Nadine Tung; Beth Y Karlan; Susan M Domchek; Judy E Garber; Kenneth Offit
Journal:  Genet Med       Date:  2021-12-03       Impact factor: 8.864

Review 2.  Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation.

Authors:  Volha A Golubeva; Thales C Nepomuceno; Alvaro N A Monteiro
Journal:  Cancers (Basel)       Date:  2019-04-12       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.